Lina Li | Senior Manager, Investor Relations |
John Leonard | Chief Executive Officer |
Glenn Goddard | Executive Vice President and Chief Financial Officer |
Andrew Schiermeier | Executive Vice President, Corporate Strategy |
Maury Raycroft | Jefferies, LLC |
Gena Wang | Barclays |
Steven Seedhouse | Raymond James |
Silvan Turkcan | Oppenheimer |
David Nierengarten | Wedbush Securities |
Geulah Livshits | Chardan Capital Markets |
Good morning. My name is Jessica and I will be your conference operator today. Welcome everyone to the Intellia Therapeutics’ First Quarter 2019 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Following the formal remarks, we will open up the call for your questions.